Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design

Research output: Contribution to journalArticleAcademic

19 Citations (Scopus)
4 Downloads (Pure)


With the event of new Molecular targets, clinical trial design requirements to perform these trials are changing. This paper discusses some of the considerations that need to be taken into account when designing a trial, including those trials that assess combinations of targets. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)196-203
Number of pages8
JournalMolecular Oncology
Issue number2
Publication statusPublished - 2012

Cite this